24hr Imaging Of HCC After EOVIST
NCT01968629
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
No eligible subject enrolled
Conditions
Hepatocellular Carcinoma
Interventions
DRUG:
Eovist
Sponsor
Massachusetts General Hospital